Brief: Bachem H1 Sales CHF 240.3 Million
25/07/2024 06:09
Jul 25 (Reuters) - Bachem H1 EBITDA CHF 55.5 million
Recent news on BACHEM HOLDING AG
See all newsSwitzerland's Bachem H1 sales rise 4.3% on growth in clinical drug development
Brief: Bachem Expects 2026 Sales Growth Between 35% And 40% In Local Currencies
Bachem jumps after announcing CHF 500 mln project investment
Brief: Bachem Holding Plans To Build Large-Scale Production Facility In Sisslerfeld
Europe Research Roundup: ABN Amro Bank, Man Group, TP